Earnings Snapshot: Tata Steel, Hindalco, SRF, Authum Investments, KIMS, Happiest Minds, Ventive Hospitality and Raymond Limited
- Share.Market
- 7 min read
- Published at : 13 May 2025 02:51 PM
- Modified at : 14 May 2025 03:44 PM
TATASTEELQ4FY25
Revenue ₹56,218 crores 🔻 4%
PAT ₹1,201 crores 🔼 116%
FY25
Revenue ₹2,18,543 crores 🔻 5%
PAT ₹3,174 crores (up from loss of ₹4,910 crores in FY24)
The company returned to profitability in Q4 and full year FY25, helped by improved performance in India. Consolidated deliveries grew 4% YoY in FY25, driven by record deliveries in India (up 9% YoY). Europe’s performance remained weak, with Q4 losses impacted by lower realizations and volumes. Tata Steel spent ₹18,207 crore on capex during FY25 and aims to grow domestic capacity to 40 MTPA.
The board recommended a dividend of ₹3.60 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting. The record date for the same is Friday, June 6, 2025.
HINDALCOQ4FY25
Revenue $4,587 million 🔼 13%
PAT $294 million 🔼 77%
FY25
Revenue $17,149 million 🔼 6%
PAT $683 million 🔼 14%
Hindalco reported strong shipment volumes for both Q4 and the full year, reflecting steady demand, particularly from the beverage packaging segment.
In Q4FY25 demand remained strong across beverage cans, aerospace, and specialty products, though automotive shipments were softer.
For the full fiscal year revenue grew supported by higher aluminium prices and a 2% increase in flat rolled product volumes. Beverage packaging hit record shipment levels, while aerospace sales also expanded. This was offset by lower volumes in the automotive and specialty categories
SRFQ4FY25
Revenue ₹4,313 crores 🔼 21%
PAT ₹526 crores 🔼 25%
FY25
Revenue ₹14,693 crores 🔼 12%
PAT ₹1,251 crores 🔻 6%
Q4FY25 was SRF’s strongest quarter of the year. This strong finish was driven by seasonal tailwinds and strong performances across the Chemicals and Performance Films businesses. The Fluorochemicals segment delivered record-high domestic sales of refrigerant gases, supported by strong demand from the room air conditioner market.
Performance Films & Foil Business saw a 216% spike in segment profit. Margin improvement came from better capacity utilization, strong demand, and increased contribution from value-added products (VAPs).
The company also filed 12 patents during the quarter, bringing the total filed to 481, with 151 granted.
AIILQ4FY25
Revenue ₹1,452 crores 🔼 9%
PAT ₹1,763 crores 🔼 15%
FY25
Revenue ₹4,579 crores 🔼 5%
PAT ₹4,241 crores 🔻 1%
Authum reported steady performance in FY25. During Q4FY25, profits surged driven by gains from strategic investments and higher interest income.
The board declared an interim dividend of ₹0.50 per equity share and 7% on preference shares for FY26. Notably, promoters holding 74.95% of equity waived their right to the dividend.
KIMSQ4FY25
Revenue ₹801 crores 🔼 26%
PAT ₹106 crores 🔼 48%
FY25
Revenue ₹3,067 crores 🔼 22%
PAT ₹415 crores 🔼 24%
KIMS reported a strong performance in Q4 and FY25, driven by higher volumes, improved ARPOB (Average Revenue per Occupied Bed), and expanded infrastructure.
Operational metrics also showed healthy growth with inpatient volumes rising 11.6% and outpatient volumes up 14.1% for the full year. ARPOB increased by 21% YoY to ₹41,469, and the hospital chain continued to invest in high-end medical technologies, such as Gamma Knife radiosurgery and TULSA-PRO for non-invasive prostate care.
The group now operates 15 hospitals with over 5,100 beds, and continues to lead in complex surgeries and organ transplants across South India. Its strong clinical outcomes, growing footprint, and consistent financial performance reinforce its position as a leading regional healthcare provider.
HAPPSTMNDSQ4FY25
Revenue ₹545 crores 🔼 31%
PAT ₹34 crores 🔻 53%
FY25
Revenue ₹2,435 crores 🔼 24%
PAT ₹185 crores 🔻 26%
Revenue for Q4 grew supported by strong momentum in the Healthcare and BFSI verticals, aided by large deal wins totalling $20 million. The company emphasized continued investments in Generative AI, strategic client initiatives, and expanding vertical-focused sales teams. International business performance remained stable, and the company maintained a healthy client base of 281 as of March 2025.
The company has announced a final dividend of ₹3.5 per share. The record date for the same is Friday, July 18, 2025.
VENTIVEQ4FY25
Revenue ₹717 crores 🔼 20%
PAT ₹151 crores
FY25
Revenue ₹2,160 crores 🔼 13%
PAT ₹256 crores
Ventive Hospitality delivered its best-ever business performance in FY25, crossing ₹2,000 crore in revenue. The company operates 11 luxury and upper-upscale hotels across India and the Maldives, with properties managed by global brands like Marriott, Hilton, and Minor. The company aims to double its room inventory over the next five years through a mix of greenfield projects, brownfield expansions, and acquisitions.
RAYMONDQ4FY25
Revenue ₹557 crores 🔼 109%
PAT ₹137 crores 🔻 40%
FY25
Revenue ₹1,947 crores 🔼 100%
PAT ₹7,636 crores 🔼 365%
Raymond Limited delivered strong performance in Q4FY25. However, total PAT (including discontinued operations like the demerged lifestyle business) stood at ₹137 crore, down 40% YoY.
The engineering business, which includes the Maini Precision acquisition, delivered a 126% YoY jump in Q4 revenue to ₹528 crore. The real estate segment reported its highest-ever quarterly revenue of ₹766 crore and maintained robust margins. With strong execution and new JDAs in place, the real estate business remains a key growth driver.
Raymond successfully demerged its real estate business during the year, with listing expected in Q2FY26. The record date for the demerger is set as May 14, 2025.
The company remains focused on scaling up its real estate and engineering segments, including further investments in aerospace and EV components.
Disclaimer
Investments in securities market are subject to market risks, read all the related documents carefully before investing. This is for informational purposes and should not be considered as recommendations.
Kindly refer to https://share.market/ for more details.
PhonePe Wealth Broking Private Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000302639, Depository Participant of CDSL Depository with SEBI Regn. No.: IN-DP-696-2022, Research Analyst with SEBI Regn No: INH000013387, BSE RA Enlistment Number: 5887, and Mutual Fund distributor with AMFI Registration No: ARN- 187821. Member ID: BSE- 6756, NSE- 90226.
Registration granted by SEBI, enlistment as Research Analyst, and Certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors
Registered office – 2, Floor 3, Wing A, Block A, Salarpuria Softzone, Service Road, Green Glen Layout, Bellandur, Bengaluru South, Bengaluru, Karnataka – 560103, INDIA.
CIN: U65990KA2021PTC146954.
